Chinese developers of cell and gene therapies continued to enjoy the limelight in July and August, although a summer lull set in for fundraisings backed by venture capital and private equity firms. Co
Device Transactions Device companies finished off 2012 raising $1.1 billion in the fourth quarter (a 40% increase over Q3’s $801 million), capping off the year with a grand total of $4 billion in fund
Device Transactions Although medical device companies had a strong opening in 2012 — they brought in $1.1 billion in Q1— the second quarter saw a dip in the money raised. While it is certainly a respe